Article

Cost-effectiveness analysis of behavioral interventions to improve vaccination compliance in homeless adults.

University of California, Los Angeles, School of Nursing, Box 956917, Los Angeles, CA 90095-6917, USA.
Vaccine (Impact Factor: 3.49). 12/2008; 27(5):718-25. DOI: 10.1016/j.vaccine.2008.11.031
Source: PubMed

ABSTRACT To estimate the cost-effectiveness of three behavioral interventions provided to enhance hepatitis A virus (HAV) and hepatitis B virus (HBV) joint vaccination (HAV/HBV) compliance among homeless persons living in Los Angeles County.
A cost-effectiveness analysis (CEA) based on data from a randomized trial where the costs and compliance data from the trial are incorporated into two Markov models, simulating the natural history of acute and chronic hepatitis infection, following HAV/HBV vaccination.
Reductions in HBV-related disease is cost-effective to society and is associated with substantial improvements in quality of life.

Download full-text

Full-text

Available from: Gerald Kominski, Jun 24, 2015
0 Followers
 · 
203 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Homeless adults have high rates of hepatitis C virus infection (HCV) and low levels of HCV knowledge. This study reports results of an interdisciplinary, community-based intervention using stakeholder cooperation, case management, risk factor identification, and modification of dysfunctional psychosocial factors to increase HCV knowledge among homeless adults (N = 747). Data are from a randomized quasi-experimental study, with the major goal of evaluating the effectiveness of a Nurse Case Managed Intervention compared to a Standard Intervention, encouraging completion of a three-series hepatitis A/hepatitis B vaccination program. Increased HCV knowledge was measured with an 18-item questionnaire discerning risk factors for HCV and common misconceptions about individuals with HCV. A significant increase in HCV knowledge resulted regardless of intervention format. Receiving the Nurse Case Managed Intervention predicted greatest gain in HCV knowledge (p < 0.000). Successfully engaging key stakeholders, outreach workers, community organizations, and homeless people themselves proved most efficacious in increasing HCV knowledge.
    The Journal of Behavioral Health Services & Research 04/2013; 41(1). DOI:10.1007/s11414-013-9333-3 · 1.03 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The study was undertaken, first, to determine the coverage rate of hepatitis B (HB) vaccine and second to evaluate the immune response to HB vaccine among children under 10 years old by measuring the level of circulating anti-HB surface antigen (anti-HBs) antibodies after immunisation with three doses. First, 840 children were randomly selected from 4 randomly selected sites in Sana'a city to study the coverage rate of the vaccine; of these, 504 children vaccinated against HBV prior to the study, were tested (56% males and 44% females). Sera were tested for anti-HBs antibodies by ELISA quantitative technique. Each individual's data was collected in a pre-designed questionnaire including: vaccination date, sex, and age at the time of the study. The coverage rate of HBV vaccine was only 69.9%, being slightly higher among male children (72.1%) than female children (66.8%). A total of 276 (54.8%) of the 504 children responded to the vaccine with anti-HBs antibody level ≥ 10 mIU/ml, while 228 (45.2%) of the 504 children had non-protective anti-HBs antibodies levels (<10IU/ml). Children of ages 3-5 years had the highest protective rate (63.6%), and the lowest protective rate was in the 9-10 years age group. This study revealed a low coverage rate of HBV vaccine and a low protective rate against HBV infection. A considerable proportion of vaccinated children should be considered for either revaccination or booster doses. There is also the need to complete HBV vaccine coverage among the child population in San'a, Yemen.
    Sultan Qaboos University medical journal 02/2011; 11(1):77-82.
  • Source